Overview
Irene Bruske practices practicing medicine in Neuherberg, Germany.
Her clinical expertise encompasses Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), Small Cell Lung Cancer (SCLC), and Asthma.
She is actively involved in clinical research, co-authoring 54 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Irene Bruske
Is Irene Bruske a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Irene Bruske is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Irene Bruske participate in research or clinical trials?
Yes. Irene Bruske has published 54 articles and abstracts on conditions like Lung Cancer. You can view a list of Irene Bruske's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AsthmaMs. Bruske isExperienced. Learn about Asthma.
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung CancerMs. Bruske isExperienced. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Ms. Bruske isExperienced. Learn about Small Cell Lung Cancer (SCLC).